GLOBAL BRIDGE CONSULTING

DIVERSITY, EQUITY AND INCLUSION

Covid-19 pandemic was a turning point in our engagement with our community, major health disparity and perceptions were uncovered as we went out to encourage uptake of the vaccine. Since then, we have established a partnership with community organizations as well as medical professionals of African descent in the US and Africa.
Our role is to help pharmaceutical and healthcare companies develop a diversity, equity and inclusion (DEI) strategic plan. This reduces, and ultimately eliminates disparities by providing valuable input on DEI goals of companies we work with. This helps them to better design clinical trials, engage more diverse patients and principal investigators in the drug development process.
We are a certified minority business entity (MBE), member of the National Minority Supplier Diversity Council (NMSDC) and Historically Underutilized business (HUB) certified.

PROFESSIONAL AND
CLINICAL SUPPORT

The last decade has seen an increased use of biologics, other complex therapies, as well as complexities in navigating the healthcare system. There is also need for diversity in clinical and post marketing data reporting. Our relationship with a network diverse healthcare professionals, patients, governments, and service providers enables us to lead them to the right organization and carry out duties such as;
  • Medication therapy management (MTM)
  • Comprehensive medication review (CMR)
  • Drugs authentication and quality checks.
  • Complex diseases state management (DSM)
  • Pharmaceutical auditing (GDP, GCP and GVP)
  • Pharmacovigilance and Drug Safety.
  • Clinical Trials sourcing and consulting.

GLOBAL AND PUBLIC HEALTH

As a company with an extensive footprint in Africa, and team members with variety of expertise, GLOBAL BRIDGE Pharmaceutical has partnered with experts and other organizations to provide solution to pharmaceutical supply chain and healthcare challenges in developing countries. Some of these projects are sponsored by the United States government, United States Agency for International Development (USAID), the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and other public and private entities foundations.

Our core strengths include:

  • Access to medicines and vaccines programs.
  • Access to medicines and vaccines programs.
  • Pharmacovigilance and drug safety (PV/DS)
  • Healthcare management and IT solutions.
  • Maternal and infant mortality projects.
  • Health systems strengthening.
  • Manufacturing, procurement, logistics and governance.
  • Pharma project management and auditing.

GOVERNMENT AND PRIVATE ENTITIES

GLOBAL BRIDGE Pharmaceutical is a Certified Minority Business Entity (MBE), National Minority Supplier Diversity Council (NMSDC) and System Award Management (SAM) registered to do business with local, state, and federal government agencies as well as other privately-owned entities.
As a specialized procurement and consulting healthcare company, we directly serve these agencies or we leverage our capabilities to work with other partners or prime contractors as a subcontractor to deliver products or services in a timely manner, while exceeding expectations.
We are also registered with the Office of Diversity and Inclusion of major corporations.

PROFESSIONAL SUPPORT

At Global Bridge, we understand the importance of having access to up-to-date guidelines on drug therapy and medical information in your practice or hospital system. Utilizing data and resources available in the United States, we can collaborate with the pharmacy and therapeutics committee (PTC) of your hospital or organization to develop a drug formulary based on the most recent guidelines.
We help our partners participate in training and workshops in the United States that fit their learning goals. In doing so, we equip them for world-class health-care delivery.

DRUG QUALITY CONTROL

Counterfeit and fake medicines are a growing trend especially in less regulated markets. In developing countries, the risk of getting caught and penalized for producing or selling fake medicines is low due to less regulation and oversight by authorities. Hundred of thousands of patients die every year from fake or counterfeit medicines. 

Despite the emergence of new technology and on site quality control devices, there are still many limitations to the drugs that can be analyzed as well as the result that these services provide with regards to qualitative and quantitative analysis of drug samples.

Our partnership with reputable USFDA approved analytical laboratories enable us to test the authenticity of the drugs you market or dispense.  We serve pharmacies, hospitals, wholesalers, governments and international health organizations.

Contact us to learn more about our analytical services!